Expression levels of other Pol III subunits (also those shared by Pol II or Pol I), its general transcription factors and its regulators were enhanced in either luminal or HER2-overexpressing cancers, but none tended to be specifically overexpressed in the basal breast cancer subtypes (Figure 2B–D). This evidence concerns the gene ERBB2 and breast cancer.